Press the button and be introduced to a new random company!

Introduce me >

UPCOMING EVENTS

We arrange several open investor events with our covered companies each year. Please subscribe to get information about our upcoming Introduce events. 

Sign up >

Social media

facebook   Meet us at Facebook

facebook   Follow us on Twitter

   Follow us on LinkedIn

Handicare

Handicare is a Swedish-based leading provider of mobility solutions and patient-handling products for the elderly and physically-challenged population. Handicare is a global company, with close to 1,200 employees and sales in more than 20 countries. It has manufacturing and assembly plants in Europe, North America and Asia.

The main opportunity for Handicare would be to gain market share in the global Accessibility and Patient Handling markets.

We note a number of risk factors for Handicare, including market risk, competition, legal and regulatory risk, product development risk, and currency and macroeconomic risk.

Financials

EURm 2018 2019e 2020e
Sales 291 305 318
Sales growth (%) 2,3 4,9 4,2
EBITDA 23 31 35
EBITDA margin (%) 7,8 10,3 11,1
EBIT adj 16 22 25
EBIT adj margin (%) 5,6 7,2 8
Pretax profit 12 19 23
EPS rep 0,19 0,29 0,33
EPS growth (%) 338 50,5 12,7
EPS adj 0,31 0,37 0,4
DPS 0,05 0,07 0,1
EV/EBITDA (x) 11,9 9,2 7,9
EV/EBIT adj (x) 16,6 13,2 10,9
P/E (x) 16,7 13 11,5
P/E adj (x) 10,5 10,3 9,4
EV/sales (x) 0,9 0,9 0,9
FCF yield (%) 8,2 6,6 7,8
Dividend yield (%) 1,6 2 2,7
Net IB debt/EBITDA 3,5 2,2 1,6
EURm 2018 2019e 2020e
Sales 291 305 318
COGS -171 -177 -183
Gross profit 120 129 135
Other operating items -97 -97 -100
EBITDA 23 31 35
Depreciation on tangibles -4 -4 -4
Depreciation on intangibles 0 0 0
EBITA 19 28 31
Goodwill impairment charges 0 0 0
Other impairment and amortisation -6 -6 -6
EBIT 13 22 25
Other financial items 2 0 0
Net financial items -1 -3 -2
Associated income 0 0 0
Other EO items 0 0 0
Pretax profit 12 19 23
Tax -1 -2 -4
Net profit 11 17 19
Minority interest 0 0 0
Net profit discontinued 0 0 0
Net profit to shareholders 11 17 19
EPS 0,19 0,29 0,33
EPS Adj 0,31 0,37 0,4
Total extraordinary items after tax -2,3 0 0
Tax rate (%) -5,6 -12 -18
Gross margin (%) 41,1 42,2 42,4
EBITDA margin (%) 7,8 10,3 11,1
EBITA margin (%) 6,5 9 9,8
EBIT margin (%) 4,5 7,2 8
Pretax margin (%) 4,1 6,4 7,4
Net margin (%) 3,9 5,6 6
Growth rates Y/Y 2018 2019 2020
Sales growth (%) 2,3 4,9 4,2
EBITDA growth (%) 0,2 39,2 11,8
EBIT growth (%) -5,9 65,9 16,2
Net profit growth (%) 337,6 50,5 12,7
EPS growth (%) 338 50,5 12,7
Profitability 2018 2019 2020
ROE (%) 6,8 9,6 10
ROE Adj (%) 10,7 12,1 12,3
ROCE (%) 6 9,3 10,8
ROCE Adj(%) 9,4 11,5 13
ROIC (%) 4,9 7,7 8,2
ROIC Adj (%) 6,1 7,7 8,2
Adj earnings numbers 2018 2019 2020
EBITDA Adj 26 31 35
EBITDA Adj margin (%) 8,8 10,3 11,1
EBITA Adj 22 28 31
EBITA Adj margin (%) 7,5 9 9,8
EBIT Adj 16 22 25
EBIT Adj margin (%) 5,6 7,2 8
Pretax profit Adj 21 25 29
Net profit Adj 18 22 24
Net profit to shareholders Adj 18 22 24
Net Adj margin (%) 6,2 7 7,4
EURm 2018 2019e 2020e
Short-term debt 0 0 0
Accounts payable 30 26 27
Other current liabilities 20 23 23
Total liabilities and equity 379 327 336
Net IB debt 80 68 55
Net IB debt excl. pension debt 80 68 55
Capital invested 251 253 255
Working capital 29 34 37
EV breakdown 2018 2019 2020
Market cap. diluted (m) 189 222 222
Net IB debt Adj 80 68 55
Market value of minority 0 0 0
Reversal of shares and participations 0 0 0
Reversal of conv. debt assumed equity 0 0 0
EV 269 290 277
Capital efficiency (%) 2018 2019 2020
Total assets turnover (%) 87,8 89,6 92,6
Capital invested turnover (%) 115,4 121,3 125,3
Capital employed turnover (%) 115,2 121,1 125,1
Inventories / sales (%) 12,2 11,9 12,1
Customer advances / sales (%) 7,3 7 7,2
Payables / sales (%) 9,5 9,2 8,3
Working capital / sales (%) 10,1 10,2 11,2
Financial risk and debt service 2018 2019 2020
Net debt / equity (%) 46,5 36,6 27,5
Net debt / market cap (%) 32,5 30,6 24,8
Equity ratio (%) 51 53,6 58,6
Net IB debt adj. / equity (%) 46,5 36,6 27,5
Current ratio (%) 211 241,5 231,2
EBITDA / net interest (%) 760,9 1258,2 1757,9
Net IB debt / EBITDA (%) 352,6 216 156,8
Interest cover (%) 615,6 727,6 829
EBITDA 23 31 35
Net financial items -1 -3 -2
Paid tax -2 -2 -4
Non-cash items 2 0 0
Cash flow before change in WC 22 27 29
Change in WC 1 -5 -4
Operating cash flow 23 22 25
CAPEX tangible fixed assets -2 -3 -4
CAPEX intangible fixed assets -4 -4 -4
Acquisitions and disposals -1 0 0
Free cash flow 16 15 17
Dividend paid -3 -3 -4
Share issues and buybacks 0 0 0
Other non cash items -3 0 0
Decrease in net IB debt 10 12 13
Balance Sheet (EURm) 2018 2019 2020
Goodwill 163 163 163
Indefinite intangible assets 0 0 0
Definite intangible assets 49 47 46
Tangible fixed assets 10 9 9
Other fixed assets 8 8 8
Fixed assets 230 227 226
Inventories 36 37 40
Receivables 44 45 48
Other current assets 3 3 3
Cash and liquid assets 24 32 25
Total assets 336 346 342
Shareholders equity 171 185 200
Minority 0 0 0
Total equity 171 185 200
Long-term debt 103 100 80
Pension debt 0 0 0
Convertible debt 0 0 0
Deferred tax 8 8 8
Other long-term liabilities 3 3 3
EURm 2018 2019e 2020e
Shares outstanding adj. 59 59 59
Fully diluted shares Adj 59 59 59
EPS 0,19 0,29 0,33
Dividend per share Adj 0,1 0,1 0,1
EPS Adj 0,31 0,37 0,4
BVPS 2,91 3,15 3,4
BVPS Adj -0,69 -0,42 -0,15
Net IB debt / share 1,4 1,2 0,9
Share price 4,16 3,77 3,77
Market cap. (m) 245 222 222
Valuation 2018 2019 2020
P/E 16,7 13 11,5
EV/sales 0,92 0,95 0,87
EV/EBITDA 11,9 9,2 7,9
EV/EBITA 14,3 10,5 8,9
EV/EBIT 20,4 13,2 10,9
Dividend yield (%) 1,6 2 2,7
FCF yield (%) 8,2 6,6 7,8
P/BVPS 1,11 1,2 1,11
P/BVPS Adj -4,66 -8,95 -25,54
P/E Adj 10,5 10,3 9,4
EV/EBITDA Adj 10,5 9,2 7,9
EV/EBITA Adj 12,3 10,5 8,9
EV/EBIT Adj 16,6 13,2 10,9
EV/cap. employed 1,1 1,1 1,1
Investment ratios 2018 2019 2020
Capex / sales 2,1 2,4 2,5
Capex / depreciation 160,5 189,6 197,5
Capex tangibles / tangible fixed assets 23,8 36,3 40,7
Capex intangibles / definite intangibles 7,7 8,4 9,6
Depreciation on intangibles / definite intangibles 0 0 0
Depreciation on tangibles / tangibles 39,4 42,3 46,5

Equity Research

Read earlier research

Media

View more media

Main shareholders

Handicare

Main shareholders Share capital % Voting shares % Verified
Nordic Capital through companies 62.9 % 62.9 % 28 Feb 2019
Fjärde AP-fonden 5.1 % 5.1 % 28 Feb 2019
Danske Invest Fonder 4.2 % 4.2 % 31 Mar 2019
Nordea Fonder 3.8 % 3.8 % 28 Feb 2019
Holta Invest AS 3.4 % 3.4 % 28 Feb 2019
Janus Henderson Investors 2.9 % 2.9 % 28 Feb 2019
Lannebo Fonder 2.2 % 2.2 % 28 Feb 2019
Allianz Global Investors 1.6 % 1.6 % 31 Jan 2019
AMF Försäkring & Fonder 1.3 % 1.3 % 31 Mar 2019
Humle Fonder 1.0 % 1.0 % 31 Mar 2019
Source: Holdings by Modular Finance AB

Insider list

Handicare

Name Quantity Code Date
Jonas Arlebäck + 1 700 BUY 26 Nov 2018
Jonas Arlebäck + 1 700 BUY 26 Nov 2018
Staffan Ternström + 15 000 BUY 9 Nov 2018
Staffan Ternström + 15 000 BUY 2 Nov 2018
Staffan Ternström + 583 657 BUY 20 Aug 2018
Elisabeth Thand Ringqvist + 5 000 BUY 28 Mar 2018
Claes Magnus Åkesson + 25 000 BUY 10 Oct 2017
Boel Sundvall + 8 000 BUY 9 Oct 2017
Claes Magnus Åkesson + 25 000 BUY 9 Oct 2017
Johan Ek + 4 000 BUY 9 Oct 2017

Show More